Novavax

The European Commission has granted approval for the Nuvaxovid XBB.1.5-adapted COVID-19 vaccine, a groundbreaking step in the fight against the ever-evolving pandemic. Developed by Novavax, this marks the first protein-based vaccine tailored to address the unique challenges posed by the autumn-winter season.

Pharmaceutical giant Pfizer said it plans a cost-cutting operation if its co-developed with BioTech COVID-19 vaccine and antiviral treatment for the coronavirus continue to underperform in the coming months due to falling demand.

Bulgaria has refused to supply the fifth vaccine approved by the European drug regulator against COVID-19 of the American company Novavax, and the decision was made by the caretaker government in August. This became clear from the answers of the Minister of Health Asena Serbezova to the GERB MP Kostadin Angelov (former Minister of Health) during the Friday parliamentary control.

Under the new rules, only travelers who have received three doses of the coronavirus vaccine can enter the country without additional documents.
According to the new Regulation on the COVID-19 regime for entry into Austria, the list of high-risk countries no longer applies.

Another vaccine against Covid, trialled in the UK and bought by the government, has been shown to be nearly 90% effective and work against the UK and South African variants of the virus.

Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work- though not as well- against new mutated versions of the virus circulating in that country and South Africa.

The European Union has concluded preliminary talks with U.S. firm Novavax to secure up to 200 million doses of its COVID-19 vaccine candidate, a Commission spokesman said on Thursday.

"The envisaged contract foresees the possibility for member states to buy 100 million doses with the option of buying another 100 million doses," the spokesman said. [Reuters]
 

Britain has agreed to spend 3.7 billion pounds on Covid-19 vaccines and in most cases will bear the liability if claims are made against the pharmaceutical companies involved.

Documents related to the Pfizer coronavirus vaccine were illegally accessed during a cyberattack at the EU regulator, the company said on Dec. 9, as Germany and other northern hemisphere countries grappled with a winter surge in the pandemic.